Hésitations Vaccinales: Observatoire HESIVAXs

🚨BREAKING STUDY — Ivermectin-Based Treatment Protocols Linked to 100% Survival in Hypoxemic COVID-19 Patients

Here's what the two-part peer-reviewed study found 👇

1️⃣ Rapid Recovery:
Case series from the U.S. (Hazan), Zimbabwe (Stone), and Nigeria (Babalola) showed SpO₂ improved within 24–48 hrs after starting treatment. Protocols included ivermectin, doxycycline, nanosilver, zinc, vitamin C, and vitamin D.

2️⃣ Zero Mortality:
No deaths reported among 119 treated patients—including 61 with baseline SpO₂ ≤ 90%, a severity level that typically requires hospitalization.

3️⃣ Reduced Hospitalization & Deaths:
Using self-controlled methods and external comparisons, significant reductions in hospitalizations and deaths were observed, especially in the Hazan and Stone protocols.

4️⃣ Mechanistic Support:
The multidrug approach targets all phases of COVID-19:
• Antiviral (ivermectin, doxycycline, nanosilver)
• Immune modulation (vitamin D, ivermectin)
• Anticoagulation (aspirin, enoxaparin)

5️⃣ Causality Established:
The findings meet 7 Bradford Hill criteria: temporality, strength of association, biological gradient, biological plausibility, coherence, consistency, and analogy.

6️⃣ Ethical & Urgent Use:
In line with Article 37 of the 2013 Helsinki Declaration, the results justify off-label, compassionate use of repurposed drugs during public health emergencies.

https://lnkd.in/ddDuSFaj | 37 comments on LinkedIn

🚨NEW STUDY - Flu Vaccination Linked to 27% Increased Risk of Flu

📍 Major Cleveland Clinic study (n=53,402) finds −26.9% vaccine effectiveness during 2024–25 flu season.

📊 Adjusted analysis: Vaccinated had significantly higher flu incidence than unvaccinated (HR 1.27, p = 0.007)

https://lnkd.in/gHEhNj42

Two robust studies have shown that mRNA injections can trigger IgG4 class switching—potentially increasing the risk of infections, cancer, myocarditis, and autoimmune disease.

Uversky et al: https://lnkd.in/g-3daSJw
Perez et al: https://lnkd.in/gjpMQSZn

#MFScholar

Could McCullough Foundation provide a full perspective of the MMR in Japan ? And bias their narrative as always. There is something totally different in Japan compared to the USA, and such has greater impact in explaining why MMR mandates in Japan were not necessary. In Japan, coverage of the first dose of measles vaccine, which had exceeded the target of 95.0% since fiscal year (FY) 2010, fell to 93.5% in FY 2021. Vaccination coverage increased to 95.4% in FY 2022 but varied by municipality. They also have done significant work in understanding vaccine hesitancy and addressed the issue with significant efforts to alleviate the problem. Vaccination coverage was less than 95.0% in 54.3% of municipalities. Vaccination coverage was significantly positively associated with population density and negatively associated with the proportion of single-father households, mothers aged ≥30 years, and the ADI. In

https://lnkd.in/eczSWrhG

"The problem: not only do the results not match the conclusions, the results themselves are highly dubious because the methods are bad. In fact, we don’t even need to understand the methods to know these results are questionable — the numbers in their tables don’t even add up correctly!

Last week we read a good study, so this week let’s read a bad one! Because bad research teaches us how to do better research. Buckle up, because this is a long one!"

The directionality between vaccine hesitancy and COVID-19 vaccine side-effects has not been hitherto examined. We hypothesized a nocebo effect, whereby vaccine hesitancy towards the second Pfizer vaccination dose predicts subsequent side-effects for a booster dose, beyond other effects. We expected these nocebo effects to be driven by (mis)information in males and prior experience in females. A representative sample of older adults (n = 756, mean age = 68.9 ± 3.43) were questioned in a typical cross-lagged design (wave 1 following a second Pfizer dose, wave 2 after their booster). As hypothesized, earlier vaccine hesitancy predicted subsequent booster side-effects for females (β = 0.10 p = 0.025, f 2 = 0.02) and males (β = 0.34, p < 0.001, f 2 = 0.16); effects were stronger in males (χ2Δ (1) = 4.34, p = 0.03). The (W1-to-W2) side-effect autoregression was stronger in females (β = .34, p < 0.001; males β = 0.18, p < 0.001), χ2Δ (1) = 26.86, p < 0.001. Results show that a quantifiable and meaningful portion of COVID-19 vaccine side-effects is predicted by vaccine hesitancy, demonstrating that side-effects comprise a psychosomatic nocebo component in vaccinated individuals. The data reveal distinct risk levels for future side-effects, suggesting the need to tailor public health messaging.

Cofondée par Jay Bhattacharya, nommé par Donald Trump à la tête des Instituts nationaux de la santé, la nouvelle revue “Journal of the Academy of Publi

A new systematic review has found that economic evaluation was infrequently incorporated into dynamic epidemiological modeling studies of public health and…

Le charlatanisme est dangereux par perte de chance pour certains malades, par escroquerie à l'argent pour d'autres...présent partout autour de nous il faut…

🚨BREAKING: 85-Million-Person Study Finds Increased Risks of Stroke, Heart Attack, Coronary Artery Disease, and Arrhythmia Following C-19 Vaccination (mRNA/Viral Vector)

🧠 Stroke (+240% after 1st dose) 
💔 Heart Attack (+286% after 2nd dose) 
🫀 Coronary Artery Disease (+244% after 2nd dose)
⚡ Arrhythmia (+199% after 1st dose)

📊This robust analysis compared over 46 million vaccinated individuals to a massive unvaccinated control group of nearly 40 million people.

Read article by epidemiologist Nicolas Hulscher, MPH: https://lnkd.in/gv6U8GfY

#MFScholar | 11 comments on LinkedIn

STUDY - 1,236% surge in excess cardiac arrest deaths following the 2021 COVID-19 countermeasure campaign in King County, Washington.

Nationwide, our study estimates 49,240 excess fatal cardiopulmonary arrests between 2021 and 2023. A robust ecological and temporal association was identified between the rise in excess cardiopulmonary arrest mortality and the COVID-19 countermeasure campaign campaign.
Nicolas Hulscher, MPH, Peter McCullough, MD, MPH

https://lnkd.in/gmFTy-HH

#MFScholar

Peer reviewed evidence indicates that Base Spike Detoxification (nattokinase, bromelain, and curcumin), alongside vitamin D supplementation, may significantly improve outcomes in those suffering from COVID-19 vaccine injury syndromes:

Hulscher N, Procter BC, Wynn C, McCullough PA. Clinical Approach to Post-acute Sequelae After COVID-19 Infection and Vaccination. Cureus. 2023;15(11):e49204. Published 2023 Nov 21. doi:10.7759/cureus.49204

McCullough, PA, Wynn, C, Procter, BC. (2023). Clinical Rationale for SARS-CoV-2 Base Spike Protein Detoxification in Post COVID-19 and Vaccine Injury Syndromes. Journal of American Physicians and Surgeons, 28(3), Fall 2023 90–94.

Shirasawa T. (2025). Imaging Diagnosis of and Treatment for Spike Protein-Induced Thrombosis after COVID-19 mRNA Vaccination. Mathews J Case Rep. 10(1):195.

McCullough PA, Hulscher N. Risk stratification for future cardiac arrest after COVID-19 vaccination. World J Cardiol. 2025;17(2):103909. doi:10.4330/wjc.v17.i2.103909

Hulscher N; Vickery A; McCullough PA. Resolution of Refractory COVID-19 Vaccine-Induced Myopericarditis with Adjunctive Rapamycin. Medical Research Archives, [S.l.], v. 12, n. 11, nov. 2024. ISSN 2375-1924. doi: 10.18103/mra.v12i11.6099.

Tsang HW, Chua GT, Tung KTS, et al. The protective role of vitamin D in BNT162b2 vaccine-related acute myocarditis. Front Immunol. 2025;16:1501609. Published 2025 Feb 19. doi:10.3389/fimmu.2025.1501609

Kodama S, Konishi N, Hirai Y, et al. Efficacy of vitamin D replacement therapy on 28 cases of myalgic encephalomyelitis/chronic fatigue syndrome after COVID-19 vaccination. Nutrition. Published online February 18, 2025. doi:10.1016/j.nut.2025.112718

📄 A new systematic review documents the barriers to new vaccine introduction in sub-Saharan Africa, including 33 studies concerning the introduction of 8 vaccines. The thematic analysis showed:

💉 Coordination and financing challenges for six vaccines in seventeen countries
💉 Acceptability challenges for five vaccines in ten countries
💉 Logistical challenges for two vaccines in six countries
💉 Quality service delivery challenges for three vaccines in thirteen countries.

👉 The study’s findings can assist governments and international organizations in developing policies to overcome barriers such as financing, logistics, and vaccine hesitancy. Read the fully study here: https://lnkd.in/e-yZUsGC

Authors: Soulama Fousseni, Patrice NGANGUE, Abibata Barro, Sophie Ramde, Luc Thierry Bihina, Marie Nicole Ngoufa, Souleymane BAYOULOU, Gbetogo Maxime Kiki, Ouedraogo Salfo

A new study in PLOS ONE has found that all measures of hospitalization for #COVID-19 infection were significantly lower in partly or fully vaccinated…

BREAKING - Sixth Study Confirms Negative Efficacy of C-19 Injections

Vaccine effectiveness (VE) against documented SARS-CoV-2 infection was -3.26% (95% CI… | 27 comments on LinkedIn

📋 A study of the socioeconomic factors associated with incomplete immunization coverage among children in India shows that this is significantly concentrated…

A qualitative study sought to investigate the factors influencing equitable COVID-19 vaccine delivery in the Philippines. The findings recognized political…

Authors Sue E. Peters† Children’s Health Defense, Franklin Lakes, NJ Jill Newman† Independent Researcher, Mount Pleasant, SC Heather Ray Children’s Health Defense, Franklin Lakes, NJ James A. Thorp Independent Researcher, Gulf Breeze, FL Tiffany Parotto Director and Founder of MyCycleStory℠,...